Be Careful of 'Holiday Heart Syndrome' When Enjoying Outdoor Activities in Cold Winter!
As the cold days continue with temperatures dropping below zero even during the day in January, ski resorts are in full swing.
Search results for "syndrome"
"Painkillers and Skin Decay on the Buttocks"... 51-Year-Old Man Suffers from 'This Syndrome', What Is It?
A rare case of extensive necrosis and ulceration of the skin at the injection site has been reported after the administration of a commonly used...
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year
The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...
When Tests Show Nothing Wrong: Why Children’s Stomach Pain Demands a Broader Look
A child complains of recurring stomach pain, yet medical tests reveal nothing unusual.
FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients
CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a...
American Physician, 71, Avoids Permanent Paralysis After Emergency Spinal Surgery in South Korea
A 71-year-old American physician who had long managed chronic back pain underwent emergency spinal surgery shortly...
FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients
Celltrion announced on October 7 that the U.S. Food and Drug Administration has approved an expanded pediatric...
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone
For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen...